Rick Simpson Oil (RSO) in Meriwether County, Georgia: The Complete Guide by OilWell Cannabis
If you live in Meriwether County—whether you’re in Manchester, Woodbury, Greenville, or anywhere between the rolling pines and quiet farms—you’ve probably heard the term RSO whispered in a support group, seen it mentioned in an online forum, or caught a glimpse of it on a dispensary shelf. Maybe you’re a veteran dealing with PTSD, a cancer patient searching for comfort during chemo, or a caregiver trying to ease a loved one’s chronic pain. You’re here because you want honest answers, not hype. You want to know what Rick Simpson Oil actually is, what it can and can’t do, and—most importantly—whether it’s legal, safe, and worth trying in Meriwether County, Georgia.
We’re OilWell Cannabis, a Houston‑based cannabinoid company that has spent the last five years building the most transparent, research‑anchored RSO formula on the market. We don’t hide behind vague labels. We publish every ingredient, every milligram, and every lab result. We ship nationwide, including right here to Meriwether County. And we refuse to sell hope without evidence.
This guide is the single most comprehensive RSO resource you’ll find for Meriwether County residents. We’ll walk you through Rick Simpson’s original story, why his 60‑gram protocol is historically important but medically unverified, how our modern multi‑cannabinoid formula solves the problems traditional RSO never could, and—crucially—how you can access it legally and safely in Meriwether County. No shortcuts. No sales pitch. Just everything we know, sourced from peer‑reviewed research and four years of mainstream media coverage, so you can make an informed decision for yourself or your family.
ABOUT RICK SIMPSON AND TRADITIONAL RICK SIMPSON OIL
Who is Rick Simpson?
Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He was not a doctor, scientist, or medical professional. He was a power engineer and maintenance worker—a blue‑collar tradesman whose path into cannabis advocacy began with a workplace injury and a deep distrust of the medical system that failed him.
The 1997 injury that started everything
In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from a scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post‑concussion symptoms that conventional medicine could not resolve. According to Simpson, the medications he was prescribed either failed to help or made his condition worse. When he asked his physician to consider cannabis, the request was refused .
The 1974 NIH‑Virginia study that shaped his thinking
Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, in which THC was reported to slow or shrink tumors in mice. That study—originally intended to demonstrate harm—became a foundational reference point in Simpson’s advocacy, even though its findings were never replicated in controlled human cancer trials .
The 2003 basal cell carcinoma story
In 2003, Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed the bumps disappeared within four days. No independent medical verification, biopsy confirmation, or clinical follow‑up has ever been published in a peer‑reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil and the catalyst for a global movement .
Important context: Simpson’s account is presented here as his personal testimony. The absence of clinical documentation means these events cannot be evaluated as medical evidence, but they are historically significant as the spark that ignited the RSO movement.
The crusade—spreading the oil
After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others in his community, charging nothing. By his own account, he helped people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more .
His story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film was distributed freely online and remains one of the most widely shared cannabis advocacy films of its era .
The law pushes back
Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police (RCMP) raided his property in 2005 and again in 2009. He was charged with cannabis cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe, where he continued his advocacy from abroad .
What he claimed vs. what the evidence shows
Throughout his public career, Simpson maintained that cannabis oil could cure cancer and many other diseases, and that pharmaceutical companies and government agencies were actively suppressing that knowledge. He framed his work as a fight against institutional corruption .
What the preclinical literature shows: In vitro and animal studies have demonstrated that THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines . These findings are scientifically interesting but have not translated into proven human cancer cures. No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer .
What institutions say: The U.S. National Cancer Institute acknowledges preclinical anticancer research but does not endorse cannabis as a cancer treatment. The FDA has not approved any cannabis plant product for cancer. Health Canada has never approved RSO for cancer. NCCIH identifies the strongest cannabinoid evidence for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure [1].
What he got right: Simpson drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. He helped create the cultural and political conditions for today’s legal cannabis industry. The term “RSO” remains the most recognized name for full‑spectrum cannabis extract .
What he overstated: The leap from preclinical signals to cancer cure was never supported by human evidence, and encouraging patients—especially cancer patients—to rely on RSO in place of proven oncologic therapies carries genuine harm potential .
THE TRADITIONAL RSO PROTOCOL
Simpson’s core treatment recommendation was a structured oral protocol designed to deliver 60 grams of concentrated cannabis oil over roughly 90 days. Below is the exact titration schedule he described.
| Phase | Dose (approx.) | Frequency | Daily Total | Notes |
|---|---|---|---|---|
| Week 1 | Half a grain of rice (10‑15 mg oil) | 3× daily | 30‑45 mg | Start very small to adjust to psychoactive effects |
| Weeks 2‑5 | Double every 4 days | 3× daily | Escalate to ~1 g/day by week 5 | Build tolerance gradually |
| Weeks 5‑12 | ~1 g (1,000 mg) | 3× daily | ~1 g/day | Continue until 60 g is consumed |
| Post‑protocol | 1‑2 g/month | As needed | 1‑2 g/month | Indefinite maintenance |
Administration methods:
- Primary—oral: Place under tongue or swallow for systemic absorption.
- Secondary—topical: Apply directly to skin lesions (Simpson combined oral + topical for skin cancer).
- Not recommended as primary—inhalation: Simpson acknowledged vaping for immediate symptom relief but insisted oral dosing was essential for sustained treatment.
Important safety context
- No controlled trial validation. There are no published human trials of this protocol.
- Unstandardized material. Traditional RSO potency varied widely; THC content could range from 60% to 90% by weight.
- Extremely high THC exposure. At peak dosing (1 g/day of 60‑90% THC oil), patients consumed 600‑900 mg of delta‑9 THC daily—far exceeding anything studied in clinical settings (FDA‑approved dronabinol is typically 2.5‑20 mg/day).
- Real risks: Severe intoxication, anxiety, panic, tachycardia, hypotension, cannabis use disorder, and impaired driving. These risks are well‑documented in the GENERAL KNOWLEDGE section [1][13][14][15].
- Oncology complexity. Patients with active cancer are medically complex; using unregulated oil as a primary treatment can cause harm beyond the oil itself.
TRADITIONAL RSO VS. MODERN FORMULATED RSO
| Dimension | Traditional RSO | OilWell Formulated RSO |
|---|---|---|
| Source material | Single high‑THC indica strain | Multi‑cannabinoid blend from multiple hemp sources |
| Extraction method | Naphtha or isopropyl alcohol (toxic) | Food‑grade ethanol or CO₂ (solvent‑free blending) |
| Cannabinoid profile | THC‑dominant, uncontrolled, never lab‑verified | Seven defined cannabinoids at specific mg amounts |
| Terpene content | Destroyed by high‑heat process | Live terpenes at 5% with a defined seven‑terpene profile |
| THCa preservation | No—fully decarboxylated by heat | Yes—1,500 mg THCa included as a separate ingredient |
| Delta‑9 THC | 600‑900 mg/day at peak dosing | 90 mg total in entire 30 mL bottle (3 mg/mL) |
| Standardization & testing | None—every batch different | Full panel third‑party lab testing; COAs available |
| Product formats | Single thick oil in syringe | Sublingual oil (30 mL) and vape cartridge (1 g) |
| Safety | Residual solvent risk, unknown potency | Solvent‑free, pesticide‑screened, heavy‑metal tested |
| Legal status | Illegal under federal law (Schedule I) | Farm Bill compliant (<0.3% delta‑9 THC) |
| Access | Underground, no shipping | Ships nationwide and internationally to legal jurisdictions |
ABOUT OILWELL CANNABIS AND OUR RSO FORMULA
The origin of OilWell Cannabis
We were founded by Colin Valencia right here in Houston, Texas. Colin grew up in McAllen, Texas—on the border with Reynosa, Mexico—in one of the most economically challenged and dangerous regions along the U.S.‑Mexico border. By sixteen, after witnessing violence that took friends to prison or worse, he left home and learned to hustle, working across the border. He chose cannabis over darker paths, learning the plant intimately in the traditional, pre‑legalization world.
Later, Colin became a formally trained software engineer and did custom development for Baylor College of Medicine—one of the most prestigious medical institutions in the Texas Medical Center. That combination of deep cannabis plant knowledge and medical‑grade technical precision defines everything we do.
Bentley’s story—the day OilWell was born
The company’s origin story begins with a dog named Bentley. Bentley was more than a pet; he was family. When Bentley fell seriously ill, veterinarians said the only humane option was euthanasia: his back legs were paralyzed, and pain meds would destroy his internal organs. Colin refused to give up.
A rescue worker named Jessica asked a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?” Colin had never explored the therapeutic side of cannabis. He learned to create CBD golden paste—a specialized cannabinoid formula for pets. Within days, Bentley got up and brought his ball to play. From paralyzed to playing fetch. Dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.
Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed formulas for every age‑related condition Bentley faced:
- Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection.
- Dementia → CBC’s role in neurogenesis.
- Glaucoma → THC’s CB1 agonism for intraocular pressure reduction.
- Crippling arthritis → Multi‑pathway anti‑inflammatory synergy using CBD, CBG, THCa, and beta‑caryophyllene.
Single cannabinoids were not enough. Bentley’s evolving conditions required a seven‑cannabinoid synergy. This is why our RSO contains CBD, CBG, delta‑8 THC, THCa, delta‑9 THC, CBN, and CBC—each at precise, lab‑verified amounts.
Colin’s own battle—PTSD and benzodiazepine addiction
Colin also knows pharmaceutical dependence personally. He used the same cannabinoid knowledge that kept Bentley alive to quit Xanax cold turkey—a feat that is notoriously difficult and dangerous. Our Peace Gummies were born from midnight experiments during benzo withdrawal. To this day, Colin personally uses the vape form of the Peace Gummies formula to manage his insomnia and severe PTSD. This is not theoretical—he lived what RSO patients live.
Our philosophy—four principles that guide everything we do
-
Accessibility over gatekeeping. No medical card required. Anyone age 21+ can purchase. We ship nationwide, including to Meriwether County, GA, and internationally where hemp-derived products are legal. Rick Simpson believed medicine should be accessible; we built a legal distribution model that makes it so.
-
Patient‑controlled potency. We preserve 1,500 mg of THCa in its acidic, non‑psychoactive form. You decide whether to use it raw (zero high) or decarboxylate it at home into delta‑9 THC for full psychoactive strength. Simpson said patients should control their medicine; we engineered the product so you can.
-
Open‑source formulas. We publish every cannabinoid amount, every percentage, and the exact recipe. If you can’t afford our product, you can source the ingredients and make your own version. This is our echo of Simpson’s free‑distribution ethos.
-
Evidence‑informed, not evidence‑overstating. The GENERAL KNOWLEDGE section of this guide represents our commitment to honest education. We distinguish what’s well‑supported by human trials, what’s emerging, and what’s overstated. Simpson operated without access to peer‑reviewed literature; we have that access and use it to protect you from hype.
Farm Bill compliance and the THCa legal framework—the key to nationwide access
Our RSO is possible because of the 2018 Farm Bill (Agricultural Improvement Act), which legalized hemp and hemp‑derived products containing less than 0.3% delta‑9 THC by dry weight at the federal level.
Our RSO Sublingual Oil contains only 90 mg of delta‑9 THC in the entire 30 mL bottle—3 mg/mL—well under the legal threshold. All cannabinoids are hemp‑derived. This makes the product:
- Legal under federal law and in most states, including Georgia.
- Shippable via USPS, FedEx, and UPS to residential addresses in Meriwether County.
- No medical card required—age 21+ only.
THCa is the game‑changer. THCa (tetrahydrocannabinolic acid) is the acidic, non‑psychoactive precursor to delta‑9 THC. At the point of sale, THCa is not delta‑9 THC, so our product stays Farm Bill compliant.
You can legally convert THCa to delta‑9 THC at home. By heating the oil at 260°F (125°C) for 45–60 minutes in an oven‑safe glass container, you decarboxylate 1,500 mg of THCa into approximately 1,315 mg of delta‑9 THC. Combined with the 90 mg already present, you get roughly 1,405 mg of total delta‑9 THC—psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.
Important legal notice: THCa converts to delta‑9 THC when heated. Buyers are responsible for understanding and complying with local laws. We ship full documentation, Certificates of Analysis (COAs), and receipts. International customers accept all customs and legal risk.
Open‑source formulas—why we publish everything
We believe in radical transparency. Below are the complete, open‑source formulas for our two RSO products. If you can’t afford our products, you can source the individual cannabinoid distillates and isolates and blend them yourself.
CBD golden paste recipe (the original open‑source formula that saved Bentley)
Ingredients:
- ½ cup organic turmeric powder
- 1 cup water
- ⅓ cup unrefined organic coconut oil
- 1–2 tsp freshly ground black pepper (for absorption)
- CBD oil (dosage depends on pet size; consult a veterinarian)
Instructions:
- Mix turmeric and water in a saucepan over low heat, stirring continuously until a thick paste forms (7–10 minutes). Add a little more water if too thick.
- Add coconut oil and black pepper; stir until thoroughly mixed.
- Cool, then transfer to a jar with a lid. Store in refrigerator up to two weeks.
- Add CBD oil to paste before serving; start low and adjust.
Serving: Mix a small amount with pet’s food once or twice daily. Always consult a veterinarian before starting any new supplement.
This recipe—published years before our RSO formulas—shows that open‑source is not a marketing strategy; it’s our DNA.
The decarboxylation choice—three ways to use one product
| Option | Method | Result | Best for |
|---|---|---|---|
| Raw (no heat) | Use oil directly from bottle | THCa stays acidic; zero psychoactivity | Daytime functional use, driving, work |
| Fully activated | Heat oil @ 260°F for 45–60 min in oven‑safe glass | ~1,405 mg delta‑9 THC total | Nighttime therapeutic strength |
| Vape | Use RSO Vape Cartridge (auto‑decarbs at 400–450°F) | Instant conversion per puff | Fast relief (1–2 min onset) |
The conversion ratio: 1 mg THCa → 0.877 mg delta‑9 THC. You can decarb only a portion of the bottle and keep the rest raw—full control.
Solvent‑free production and third‑party testing
Traditional RSO uses naphtha or isopropyl alcohol—neither food‑grade. We eliminated that risk entirely. Our RSO is a formulated blend of individual cannabinoid distillates and isolates mixed in a controlled environment. No extraction solvents touch the final product.
Carrier: Organic MCT oil—food‑grade, neutral taste, excellent sublingual absorption.
Testing: Every batch undergoes full‑panel third‑party lab analysis:
- Cannabinoid potency (±2% accuracy)
- Terpene profile
- Pesticides (400+ compounds)
- Heavy metals (arsenic, cadmium, lead, mercury)
- Residual solvents (FDA Class 3 limits <5,000 ppm)
- Microbial contaminants (E. coli, Salmonella, Aspergillus)
Certificates of Analysis (COAs) are available on our website and ship with every order.
PRODUCT FORMATS AND PRICING FOR MERIWETHER COUNTY
We offer two delivery formats, each optimized for different needs.
RSO Sublingual Oil — $129.99
- 30 mL bottle (1 fl oz)
- Total cannabinoids: 16,590 mg (553 mg/mL)
- Cannabinoid breakdown:
- CBD: 4,500 mg
- CBG: 3,000 mg
- Delta‑8 THC: 6,000 mg
- THCa: 1,500 mg
- Delta‑9 THC: 90 mg
- CBN: 750 mg
- CBC: 750 mg
- Live terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
- Organic MCT oil base
- Graduated dropper (0.1 mL increments)
- Onset: 15–45 minutes
- Peak: 1–2 hours
- Duration: 4–6 hours
- Bioavailability: 13–19%
- Approx. 40–60 doses per bottle
RSO Vape Cartridge — $49.99
- 1 g cartridge (510‑thread universal battery compatible)
- Total cannabinoids: 900 mg+
- Same six‑cannabinoid ratio as sublingual (THCa auto‑decarbs at vaping temp)
- Live terpenes: 5%+
- Onset: 1–2 minutes (fastest delivery)
- Peak: 10–15 minutes
- Duration: 2–4 hours
- Bioavailability: 10–35% (depends on inhalation technique)
When to use each format
| Use case | Recommended format | Why |
|---|---|---|
| Fast relief (pain, nausea, panic) | Vape | 1–2 min onset |
| Sustained relief (chronic pain, sleep) | Sublingual oil | 4–6 hr duration |
| Maximum bioavailability | Sublingual oil | 13–19% absorption |
| Portability/discretion | Vape | No measuring, pocket‑size |
| Precise dose control | Sublingual oil | 0.1 mL graduated dropper |
| Daytime non‑psychoactive use | Sublingual (raw) | THCa stays inactive |
| Nighttime psychoactive use | Sublingual (decarbed) or Vape | Full THC activation |
TERPENE PROFILE (BOTH PRODUCTS)
Our seven‑terpene blend is identical in the sublingual oil and vape cartridge:
- Limonene – citrus‑bright, mood‑enhancing
- Myrcene – earthy, relaxing
- Caryophyllene (β‑caryophyllene) – pepper/spice, CB2 agonist
- Pinene – forest‑fresh, clarity
- Linalool – floral/lavender, calming
- Humulene – woody, anti‑inflammatory
- Terpinolene – piney‑fruity, complex aroma
Each terpene has a distinct evidence profile, ranging from promising preclinical work (caryophyllene’s CB2 activity) to limited human data (myrcene sedation claims). We include them because the entourage‑effect hypothesis is plausible, but we keep claims conservative.
CONDITION‑SPECIFIC USAGE CONTEXT FOR MERIWETHER COUNTY RESIDENTS
IMPORTANT DISCLAIMER: The following contexts are informed by cannabinoid research cited in this guide. They are not FDA‑approved prescriptions, not medical advice, and not a substitute for professional care. Always consult a qualified healthcare provider before using cannabinoid products—especially if you have a medical condition, take medications, are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. Individual results may vary.
Chemotherapy‑related nausea and appetite support
- Pre‑chemo: 0.5–1.0 mL sublingual ≈ 1 hour before treatment.
- Acute breakthrough nausea: 2–3 vape puffs for immediate relief (1–2 min onset).
- Post‑chemo: 0.5 mL sublingual every 6 hours as needed.
- Sleep support during treatment: 1.0–2.0 mL sublingual before bed (delivers 25–50 mg CBN).
Evidence: Delta‑8 THC antiemetic data [9]; delta‑9 THC nausea/vomiting evidence [1][13]; CBD anxiolytic buffering [3].
Chronic pain (fibromyalgia, arthritis, neuropathy)
- Daytime (non‑impairing): 0.3–0.5 mL raw sublingual (THCa stays inactive).
- Nighttime: 0.5–1.0 mL decarboxylated sublingual (combines pain relief + CBN sleep support).
- Breakthrough pain: Vape as needed for rapid onset.
Evidence: CBD pain literature [4]; delta‑9 THC pain review [13]; beta‑caryophyllene CB2 agonism [24]; THCa COX‑2 inhibition [12].
Sleep support
- Before bed: 1.0–2.0 mL sublingual.
- At 2.0 mL you receive 50 mg CBN, the dosage level studied in 2024 sleep literature.
- At 1.0 mL you receive 25 mg CBN, above the 20 mg threshold linked to reduced sleep disturbance.
Evidence: CBN sleep studies [16][17]; cannabis and sleep review [17].
Anxiety and stress
- Daytime functional relief: 0.3 mL raw sublingual (CBD + CBG address anxiety pathways, no high).
- Nighttime: 1.0 mL sublingual (full profile + CBN for sleep architecture).
Evidence: CBD anxiety meta‑analysis [3]; CBG pharmacology [7][8]; limonene entourage data [20].
COMPETITIVE COMPARISON (GENERIC)
We compare our formula to typical products on the market without naming brands, because our goal is education, not attack.
OilWell RSO vs. typical medical‑dispensary RSO (THC‑only)
| Feature | Typical dispensary RSO | OilWell RSO |
|---|---|---|
| Cannabinoid profile | THC‑only (e.g., ~420 mg THC per 0.5 g) | 7 cannabinoids (CBD, CBG, delta‑8, THCa, delta‑9, CBN, CBC) |
| CBG, CBN, CBC content | 0 mg | 3,000 mg CBG, 750 mg CBN, 750 mg CBC |
| Patient‑controlled potency | No—always psychoactive | Yes—THCa stays raw until you heat it |
| Access requirements | Medical card + qualifying condition | Age 21+, no card needed |
| Delivery | Must travel to physical dispensary | Ships to Meriwether County via USPS/FedEx |
| Farm Bill compliant | No (state medical program) | Yes (<0.3% delta‑9 THC) |
OilWell RSO vs. typical hemp‑derived RSO (CBD‑dominant)
| Feature | Typical hemp RSO (10 mL, 1,000 mg total) | OilWell RSO (30 mL, 16,590 mg total) |
|---|---|---|
| Total cannabinoids | ~1,000 mg | 16,590 mg |
| CBD content | ~950 mg | 4,500 mg |
| CBG, CBN, CBC content | Minimal (<20 mg each) | 3,000 mg CBG, 750 mg CBN, 750 mg CBC |
| Delta‑8 THC content | 0 mg | 6,000 mg |
| THCa (convertible) | Minimal | 1,500 mg (≈1,315 mg delta‑9 after decarb) |
| Psychoactive option | No meaningful effect | Yes—via THCa decarb or delta‑8 THC |
| Approximate price | $40–$50 | $129.99 |
SHIPPING & DELIVERY TO MERIWETHER COUNTY
We don’t have a storefront in Meriwether County, but we ship directly to your door via:
- USPS Priority Mail (2–3 business days)
- FedEx/UPS Ground (3–5 business days)
- Discreet packaging—no cannabis branding visible
- Tracking provided for every order
- Temperature‑stable packaging for summer heat
- Signature‑required option available
Shipping fees:
- Standard shipping (USPS): $9.99
- Expedited (FedEx/UPS): $19.99
Meriwether County delivery timeline: Most orders placed before 2 PM Central ship same day; you’ll receive tracking within 24 hours.
Contact for Meriwether County customers:
- Phone: (832) 416‑2816
- Email: [email protected]
- Website: oilwellcbd.com
Important: You are responsible for verifying that hemp‑derived products are legal in your jurisdiction. Georgia law permits hemp products with <0.3% delta‑9 THC, and our products comply. Keep documentation (COA, receipt) in case of inquiry.
MEDIA RECOGNITION—SEVEN ABC13 FEATURES, FOUR YEARS, ONE VOICE
Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin Valencia and OilWell Cannabis in seven separate news segments, covering business, law, medicine, community health, and politics. Five different reporters (Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, KTRK staff) sought Colin out—no other Houston cannabis operator matches that frequency or breadth.
Timeline of ABC13 features
| Date | Headline | Reporter | Key Quote/Context |
|---|---|---|---|
| Sep 15 2019 | Texas CBD businesses booming as industry evolves | Tom Abrahams | “I’m not trying to sell people snake oil… people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot.” |
| Mar 22 2021 | Entrepreneur creates direct‑to‑consumer business ahead of decriminalization | Tom Abrahams | “Pain comes in a lot of different forms.” |
| May 24 2021 | What is Delta‑8 THC and why is it considered “legal weed” in Texas? | Steve Campion | Colin’s iconic moment: “Maybe you want to get high.” |
| Aug 20 2021 | Houston CBD shop giving away free products to those who get COVID vaccine | KTRK Staff | Gave away 1,000 caviar pre‑rolls (~$35,000 value) to encourage vaccination; coordinated with city of Houston |
| Oct 19 2021 | Texas ban over once legal hemp product Delta‑8 raises questions | Shelley Childers | Colin proactively removed Delta‑8 products before enforcement, warned other operators they were shipping Schedule I narcotics |
| Oct 7 2022 | Biden marijuana pardon—experts weigh in on why Texas won’t see impact | Nick Natario | Revealed Colin has a personal marijuana conviction history; introduced CBD vending machine |
| Apr 21 2023 | Marijuana industry getting creative as Texas laws continue to change | Nick Natario | “Right now is actually a Renaissance… pretty important time that should be enjoyed now.” |
The through‑line—what the media record reveals
- Consistency: Across four years and five reporters, Colin’s message stayed the same—honest education, no hype.
- Community action: $35K in free product for COVID vaccination, proactive compliance during the Delta‑8 ban.
- Personal stakes: The October 2022 feature disclosed Colin’s own cannabis conviction, adding weight to every quote about therapy and justice.
- Evolution of language: From “local wholesaler” (2019) to “industry authority” (2023), the coverage tracks the maturation of both OilWell and legal cannabis in Texas.
These features cannot be purchased—they can only be earned. That’s the credibility we bring to Meriwether County.
THE EVIDENCE DEEP DIVE—WHAT THE RESEARCH REALLY SAYS
We anchor every claim in peer‑reviewed literature. Below is a concise summary of the evidence for each cannabinoid and terpene in our formula, with citation numbers referencing the full list at the end of this guide.
Cannabinoids
| Compound | Strongest Evidence | Emerging Research | Overstatement to Avoid |
|---|---|---|---|
| CBD | Seizure disorders (Epidiolex) [1][2]; modest anxiolytic signal [3] | Pain [4], sleep [5] | Not a cure‑all; liver enzyme risk [6] |
| CBG | Neuroprotective preclinical [7][8] | IBD, antibacterial | Human data still sparse |
| Δ‑8 THC | Chemo antiemetic (animal) [9] | Public‑health safety concerns [10][11] | Not milder; real psychoactivity |
| THCa | COX‑2 inhibition (preclinical) [12] | Neuroprotective (preclinical) | Converts to Δ‑9 when heated |
| Δ‑9 THC | Chemo nausea, HIV appetite [1] | Chronic pain (short term) [13] | High‑concentration mental‑health risks [15] |
| CBN | Limited; no robust sleep trials [16][17] | — | Sleep claims overstated |
| CBC | Anti‑inflammatory (preclinical) [18][19] | Neurogenesis (preclinical) | Human evidence lacking |
Terpenes
| Terpene | Key Finding | Human Data? |
|---|---|---|
| Limonene | Antioxidant, anti‑inflammatory (preclinical) [21]; oxidized form is a skin allergen [22] | Limited |
| Myrcene | Anxiolytic, analgesic (animal) [23] | No robust trials |
| Caryophyllene | Selective CB2 agonist (unique among terpenes) [24] | Preclinical only |
| Pinene | Neuroprotective (preclinical) [25] | No human trials |
| Linalool | Mood‑modulating (preclinical) [25][26]; oxidized allergen [22] | Limited |
| Humulene | Anti‑inflammatory (preclinical) [27] | Limited |
| Terpinolene | Broad biologic activity (preclinical) [28] | No human data |
Entourage effect
A 2024 comprehensive review concluded that terpene‑cannabinoid synergy is plausible but not yet robustly proven in humans [20][29]. We include terpenes because they enhance flavor and aroma and may contribute modestly to overall effect, but we avoid overstating their clinical impact.
OPEN‑SOURCE FORMULAS—THE RECIPES
RSO Sublingual Oil Formula (30 mL)
| Cannabinoid | Amount (mg) |
|---|---|
| CBD | 4,500 |
| CBG | 3,000 |
| Delta‑8 THC | 6,000 |
| THCa | 1,500 |
| Delta‑9 THC | 90 |
| CBN | 750 |
| CBC | 750 |
| Total | 16,590 mg |
- Live terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
- Carrier: Organic MCT oil
- Active per mL: 553 mg
RSO Vape Cartridge Formula (1 g)
| Cannabinoid | % by weight |
|---|---|
| CBD | 30% |
| CBG | 20% |
| Delta‑8 THC | 15% |
| THCa | 10% |
| CBN | 10% |
| CBC | 10% |
- Live terpenes: 5%+
- Thread: 510‑universal
REFERENCES—THE SOURCE MATERIAL
Rick Simpson Section (RS)
RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.
RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005. Distributed via phoenixtears.ca and online platforms.
RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates. Accessed March 2026.
RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436‑444. PMID: 22555283.
RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta‑9‑tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197‑203. PMID: 16804518.
RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024. Available at: https://www.cancer.gov/about‑cancer/treatment/cam/hp/cannabis‑pdq
General Knowledge (GK)
- National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis‑marijuana‑and‑cannabinoids‑what‑you‑need‑to‑know
- Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta‑analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.
- Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta‑analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.
- Cásedas G, Yarza‑Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.
- Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213‑229. PMID: 36149724.
- Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol‑associated hepatotoxicity: A systematic review and meta‑analysis. J Intern Med. 2023;293(6):724‑752. PMID: 36912195.
- Nachnani R, Raup‑Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204‑212. PMID: 33168643.
- Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.
- Tagen M, Klumpers LE. Review of delta‑8‑tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915‑3933. PMID: 35523678.
- LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta‑8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011‑1028. PMID: 36710464.
- Abdel‑Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta‑8‑Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.
- Moreno‑Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9‑Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124‑130. PMID: 28861488.
- McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis‑based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143‑1153. PMID: 35667066.
- Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327‑360. PMID: 12648025.
- Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High‑concentration delta‑9‑tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429‑1440. PMID: 40854216.
- Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366‑371. PMID: 34468204.
- Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712‑727. PMID: 39612156.
- Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup‑Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206‑213. PMID: 38777605.
- Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355‑364. PMID: 36654096.
- André R, Gomes AP, Pereira‑Leite C, Marques‑da‑Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.
- Anandakumar P, Kamaraj S, Vanitha MK. D‑limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.
- Ogueta IA, Brared Christensson J, Giménez‑Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez‑Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1‑12. PMID: 35122274.
- Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.
- Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor‑selective pharmacological properties and therapeutic potential of beta‑caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.
- Weston‑Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene‑based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.
- Dos Santos ÉRQ, Maia JGS, Fontes‑Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073‑1092. PMID: 34544345.
- Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha‑humulene: A scoping review. Planta Med. 2024;90(9):664‑674. PMID: 38626911.
- Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro‑Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.
- Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid‑terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344‑1364. PMID: 21749363.
FINAL WORDS FOR MERIWETHER COUNTY
If you’re in Meriwether County and you’ve read this far, you now know more about Rick Simpson Oil than most dispensary employees. You understand the difference between hope and evidence, between a crude homemade extract and a lab‑tested, seven‑cannabinoid formula. You know that THCa gives you the power to choose—daytime relief without impairment, or full‑strength therapeutic effects when you need them.
We built OilWell for people like you: folks who’ve been let down by conventional medicine, who need real options, and who refuse to be sold snake oil. We’re not here to tell you cannabis will cure cancer. We are here to give you the best‑researched, most transparent, legally accessible RSO available—and to let you decide if it’s right for you.
Order today:
- Sublingual Oil: $129.99 (30 mL, 16,590 mg total cannabinoids)
- Vape Cartridge: $49.99 (1 g, 900 mg+ cannabinoids)
We ship to Meriwether County every day. If you have questions, call us at (832) 416‑2816 or email [email protected]. We’ll answer directly—no bots, no runaround.
Thank you for trusting us with your health. We’re honored to serve Meriwether County.
— The OilWell Cannabis Team
Houston, Texas
Serving Meriwether County & Beyond
THCa Rick Simpson Oil
Full-Spectrum • In-House Extraction
THE OILWELL PASSION PROJECT: THCa RSO
Experience true full-spectrum relief. Our Rick Simpson Oil is meticulously crafted in-house to preserve the complete cannabinoid and terpene profile of the plant. Potent, pure, and profound.
- 🌿 Maximum Potency
- 🔬 Third-Party Lab Tested
- 🚀 Same-Day Delivery Available